- Lee R. Berkowitz, MD, Chair
- Jeffrey S. Berns, MD
- Marcy B. Bolster, MD
- Susan Edgman-Levitan, PA
- Serpil C. Erzurum, MD
- Marianne M. Green, MD
- Mariell L. Jessup, MD
- Sharon A. Levine, MD
- Jeanne M. Marrazzo, MD
- Paul Martin, MD
- Lesley A. Meng, MD
- Michael R. Nelson, MD
- Naomi P. O'Grady, MD
- Dana Safran, ScD
- Richard M. Stone, MD
- Henry H. Ting, MD
- Jeffrey Wiese, MD
- Michael E. Williams, MD
- William F. Young Jr., MD
The ABIM Council ensures the quality, relevance and effectiveness of ABIM's programs for Certification and Maintenance of Certification (MOC) for all physicians across the specialties and subspecialties of internal medicine. The Council establishes and pursues the continuous improvement of program standards, policies and procedures governing: the requirements for Initial Certification and Maintenance of Certification (MOC) by ABIM; qualifications of candidates applying for Certification and MOC; the method, scope and administration of Initial Certification and MOC examinations; and, the interpretation and applications of the policies and procedures.
2014 - 2015 Members
Lee R. Berkowitz, MD, Chair
Dr. Berkowitz, a board certified internist and hematologist, is the Eunice Bernhard Distinguished Professor and Associate Chair of Education in the Division of General Internal Medicine at the University of North Carolina (UNC) at Chapel Hill. His academic career has centered on his role as Residency Program Director at UNC.
Currently, Dr. Berkowitz serves as a member of the ABIM Internal Medicine Exam Writing Committee and Chair of the ABIM Council, and as Chair of the Alliance for Academic Medicine’s Task Force on Education Redesign of Graduate Medical Education. He has served as President of the Association of Program Directors in Internal Medicine and as Chair of the In-training Examination Test Writing Committee of the American College of Physicians.
Dr. Berkowitz earned his medical degree at the Ohio State University College of Medicine. He did his residency and chief residency in the Department of Medicine at the University of North Carolina at Chapel Hill and later completed fellowship training in hematology at Washington University and UNC.
Jeffrey S. Berns, MD
Dr. Berns, a board certified internist and nephrologist, is Professor of Medicine and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, where he is Associate Dean for Graduate Medical Education, Associate Chief of the Renal, Electrolyte, and Hypertension Division, and Director of the Nephrology Fellowship Training Program. Dr. Berns maintains a general nephrology practice at the Hospital of the University of Pennsylvania.
Upon completion of fellowship, Dr. Berns entered private practice, first in Northern Virginia then in Philadelphia and remained in private practice for about 12 years before joining the faculty of the University of Pennsylvania.
Dr. Berns serves as Educational Series Editor for the Clinical Journal of the American Society of Nephrology, Dialysis Section Co-editor for UpToDate, and Assistant Editor of Seminars in Dialysis. He is National Kidney Foundation-KDOQI Vice-Chair for Clinical Practice Guidelines and Commentaries. He serves on the ABIM Nephrology Subspecialty Exam Committee and served previously on the ABIM Nephrology SEP Committee. He is President-Elect of the National Kidney Foundation. He has received numerous teaching awards, including the Christian R. and Mary F. Lindback Award for Distinguished Teaching from the University of Pennsylvania. He is also the recipient of the Exemplar of Humanism in Medicine Award from the College of Physicians of Philadelphia.
Dr. Berns received his medical degree from Case Western Reserve University in Cleveland, Ohio. He completed his internal medicine internship at University Hospitals of Cleveland and then his nephrology fellowship at Yale University.
Marcy B. Bolster, MD
Dr. Bolster, a board certified rheumatologist, is an Associate Professor of Medicine at Harvard Medical School. She is the Director of the Rheumatology Fellowship Training Program in the Division of Rheumatology, Allergy and Immunology at the Massachusetts General Hospital. She sees patients in the Rheumatology and Endocrine Associates Outpatient Clinics.
Prior to her position at the Massachusetts General Hospital, she was a Professor of Medicine in the Division of Rheumatology and Immunology at the Medical University of South Carolina, where she was on faculty from 1993-2012. She also served as the Director, Rheumatology Fellowship Training Program, the Medical Director, Center for Osteoporosis and Bone Health and the Medical Director, Musculoskeletal Institute at MUSC.
Dr. Bolster is a fellow of the American College of Physicians, a member of the American College of Rheumatology (ACR), a member of the International Society for Clinical Densitometry and a member of the American Society for Bone Mineral Research. She is the Chair, ACR Committee on Training and Workforce and co-leader for the ACR in the ACGME Next Accreditation System. She is a member of the ACR Board of Directors and of the Rheumatology Research Foundation Board of Directors. She has served on the American Board of Internal Medicine Rheumatology Board (2009-14) and will be the Chair, ABIM Rheumatology Test-Writing Committee and ABIM Rheumatology Subspecialty Board (2014).
Dr. Bolster is a charter member of the MGH Women’s Midlife Health Center. She has demonstrated an interest both in curriculum development and graduate medical education. She is a charter member of the Carolinas Fellows Collaborative. She previously served as the Co-chairperson for the Rheumatology Intraining Examination (2006-2009). Dr. Bolster previously served on the ACR Committee on Training and Workforce (2007-2010) and was the Chair for the sub-committee on Resident Education (2008-2010) which spearheaded the development of “Rheum2Learn”, an online internal medicine resident education tool for rheumatology. She was a contributing author to MKSAP 14- Rheumatology and was the book editor for MKSAP 15- Rheumatology.
Dr. Bolster obtained a bachelor’s degree in Chemistry and her medical degree from Duke University. She trained in internal medicine at the Eastern Virginia Graduate School of Medicine and obtained rheumatology sub-specialty training at the Medical University of South Carolina (MUSC).
Susan Edgman-Levitan, PA
Susan Edgman-Levitan, PA, is Executive Director of the John D. Stoeckle Center for Primary Care Innovation at Massachusetts General Hospital (MGH). Prior to coming to MGH, she was the founding President of the Picker Institute. She is a Lecturer in the Department of Medicine, Massachusetts General Hospital and an Associate in Health Policy, Harvard Medical School.
A constant advocate of understanding the patient’s perspective on health care, Susan has been the co-principal investigator on the Harvard Consumer Assessment of Health Plans Study (CAHPS) study from 1995 to the present and she is the IHI Fellow for Patient and Family-Centered Care. She is an editor of Through the Patient’s Eyes, a book on creating and sustaining patient centered care, The CAHPS Improvement Guide, and has authored many papers and other publications on patient-centered care. She is a co-author of the Institute of Medicine 2006 report, The Future of Drug Safety: Promoting and Protecting the Health of the Public.
Ms. Edgman-Levitan serves on several boards and national advisory committees, including the Foundation for Informed Medical Decision Making, the National Patient Safety Foundation, the National Health Services Corps Advisory Council, the Patient-Centered Primary Care Collaborative, and is a member of the Lucian Leape Institute.
Ms. Edgman-Levitan is a graduate of the University of Michigan and the Duke University Physician Assistant program where she received the Distinguished Alumni award from the Duke Physician Assistant Program and was inducted into the Duke University Medical Center Hall of Fame in 2004. Ms. Edgman-Levitan was awarded the 2007 Leadership and Innovation award from the Center for Information Therapy.Top
Serpil C. Erzurum, MD
Dr. Erzurum, a board certified internist and pulmonary disease specialist, is the Alfred Lerner Chair of the Department of Pathobiology in the Lerner Research Institute, and the Program Director of the Cleveland Clinic Clinical Research Unit of the Case Clinical Translational Science Center. In these roles, she led development of translational multidisciplinary research programs to investigate human diseases. Since 1993, she practices as a Pulmonologist at the Cleveland Clinic.
Prior to the Cleveland Clinic, Dr Erzurum practiced at the University of Pittsburgh Medical Center, in the Indian Health Service in South Dakota, and as a Senior Staff Fellow in the Pulmonary Branch of the National Heart Lung and Blood Institute (NHLBI). Over the past 25 years, her NIH-funded studies of asthma and pulmonary vascular diseases have uncovered mechanisms and led to new therapeutic concepts.
She is a member of the Board of External Experts and Board of Scientific Counselors for NHLBI, and a Councilor of the Association of American Physicians. She chairs the research committee of the Scientific Leadership Council of the Pulmonary Hypertension Association, and has been a Senior Fellow of the American Asthma Foundation. She is Deputy Editor of the American Journal of Respiratory and Critical Care Medicine since 2009.
Dr. Erzurum received her medical degree from Northeastern Ohio Universities College of Medicine. Following medicine residency at Baylor College of Medicine, she trained in pulmonary and critical care at the University of Colorado and National Jewish Center.
Marianne M. Green, MD
Dr. Green, board certified in internal medicine, is Associate Dean for Medical Education and Competency Achievement and Director of the Honors Program in Medical Education at the Northwestern University Fienberg School of Medicine.
Over the course of her career she has led several education initiatives, most recently as Administrative Leader for the Competency-Based Education Initiative and summative portfolio review as an assessment method of competence. She is working with AAMC on the latter initiative. She has received numerous awards and honors, including the Harvard Macy Fellowship for Assessment in Medical Education and the George H. Joost Outstanding Teacher Award. Dr. Green is also an inaugural member of the Fienberg Academy of Medical Educators. In addition to her academic roles, Dr. Green directs patient care at the outpatient General Internal Medicine Clinic. She has authored multiple papers and is a reviewer for several medical journals including JAMA, Archives of Internal Medicine and Annals of Internal Medicine.
Dr. Green served as Chair of ABIM’s Internal Medicine Test Writing Committee. She is on the Liebman Scholarship Selection Committee for Northwestern University as well as the Augusta Webster Grant for Educational Intervention Selection Committee.
She received her medical degree from the University of Illinois, Chicago School of Medicine and went on to complete her internship and residency at Beth Israel Hospital, Harvard Medical School.
Mariell L. Jessup, MD
Dr. Jessup, who is board certified in Internal Medicine, Cardiovascular Disease and Advanced Heart Failure and Transplant Cardiology, is Professor of Medicine at the University of Pennsylvania School of Medicine, Associate Chief-Clinical Affairs, Cardiovascular Division of Medicine, and Medical Director of the Heart and Vascular Center at Penn Medicine, where she works with a multi-disciplinary team of cardiologists, cardiac and vascular surgeons, nurse practitioners and nurses to deliver collaborative, cutting-edge care to patients. Dr. Jessup’s focus throughout her career has been on the optimal management of patients with heart failure, including the appropriate selection of patients for heart transplant or ventricular assist devices.
She has been a member of the committee to revise ACC/AHA Guidelines for the Management of Heart Failure, published in 2001 and most recently in 2005. She was the Chair of the ACC/AHA Guidelines focused update for heart failure published in March, 2009. She is now the Vice-Chair of that same committee. Dr. Jessup served on the American Heart Association’s Council of Clinical Cardiology Program Committee, and was a member-at-large on the AHA annual meeting’s program committee. She served for two years as the Chair of the Committee for Scientific Sessions Program of the AHA. She is a member of the Board of Directors of the national AHA and became President of the American Heart Association in June of 2013. She completed a 4-year term as an ABIM representative for the Residency Review Committee-Internal Medicine of the ACGME, and a 6-year term on the ABIM’s Cardiovascular Board. She has now joined the Board of the Advanced Heart Failure and Transplant cardiology secondary subspecialty, and is the Chair as of June 2012. She served as the Co-chairman of the ISHLT’s Heart Failure Council, and served on the Board of Directors of the ISHLT for three years. She was a member of the Executive Council of the Heart Failure Society of America, and recently served as the secretary for the HFSA. She is on the Steering committee of the INTERMACs registry for ventricular assist devices.
Dr. Jessup has published numerous articles as well as editorials, reviews, chapters and reports from committees on heart failure, as well as heart transplant. She has been recognized by The Best Doctors in America and in Philadelphia Magazine’s Top Docs issue.
Dr. Jessup received her bachelor of arts degree from the University of Pennsylvania and a medical degree from Hahnemann Medical College in Philadelphia. She completed her residency in internal medicine at Hahnemann University Hospital and a cardiovascular fellowship at the Hospital of the University of Pennsylvania.
Sharon A. Levine, MD
Dr. Levine is a board certified internist and geriatrician and Professor of Medicine at Boston University School of Medicine, where she served as the Associate Dean for Academic Affairs. She is currently the Director of Geriatric Educational Innovations in the Geriatrics Section.
Dr. Levine has also been the Director of Education and the program director for the geriatric medicine, oncology and dentistry fellowships and PI on the HRSA-funded Geriatrics Training Program for Physicians, Dentists, and Behavioral and Mental Health Professionals. Additionally, she provides clinical care for homebound elders and teaches students and fellows as part of the Boston University Geriatrics Services Home Care Program.
Among her many significant contributions to geriatrics education, Dr. Levine created Boston University’s Chief Resident Immersion Training (CRIT) in the Care of Older Adults. The program focuses on providing chief residents with knowledge and confidence to practice and teach geriatrics and to develop leadership and teaching skills needed in their chief resident roles. The program has been offered at 19 other institutions nationwide, through national dissemination projects supported by the John A. Hartford Foundation, the Hearst Foundations and the Donald W. Reynolds Foundation, which will bring the model to 40 institutions by 2015.
A member of the American Board of Internal Medicine’s Council, Dr. Levine is Chair of the ABIM Subspecialty Board on Geriatric Medicine. She is also a fellow of the American Geriatrics Society (AGS). She was awarded the AGS’s Dennis W. Jahnigen Memorial Award in 2011 for her outstanding leadership in advancing geriatrics education in health professions schools. She is also the winner of Boston University’s prestigious Metcalf Cup and Prize, the Society of General Internal Medicine’s New England Educator of the Year award, and the Boston University Department of Medicine’s Robert Dawson Evans Special Recognition Teaching Award. Dr. Levine has served on numerous national education committees and has supported and inspired trainees at all levels. She has authored peer-reviewed publications that focus on the dissemination of innovative teaching models and faculty development programs in geriatrics.
She received her medical degree from Albert Einstein College of Medicine and completed her residency in Internal Medicine at Yale-New Haven Hospital, where she taught before coming to Boston.
Jeanne M. Marrazzo, MD
Dr. Marrazzo, board certified in internal medicine and infectious diseases, is Professor in the Division of Allergy & Infectious Diseases, University of Washington, Seattle. She is Co-Chair of the CDC/HRSA Advisory Committee on HIV/AIDS, Associate Editor of the journal Sexually Transmitted Diseases, immediate past President of the American STD Association, and Medical Director of the Seattle STD/HIV Prevention Training Center. Most recently, she led the VOICE Study, a large study evaluating HIV pre-exposure prophylaxis administered vaginally and orally to women at high risk for HIV infection in sub-Saharan Africa conducted by the NIH-funded Microbicide Trials Network. She is a Fellow of the American College of Physicians and of the Infectious Disease Society of America, and has been Principal Investigator for numerous studies of clinical and epidemiologic aspects of reproductive tract infections. Other major areas of research interest include the genital microbiome, pathogenesis and management of bacterial vaginosis, STD in HIV-infected persons and diagnosis and screening of bacterial STDs.
In addition to her service on the ABIM Council, Dr. Marrazzo is the Chair of ABIM’s Infectious Disease Subspecialty Board.
Dr. Marrazzo obtained her undergraduate degree from Harvard and Radcliffe College and medical degree from Jefferson Medical College. She completed residency training and chief residency in internal medicine at Yale-New Haven Hospital. She obtained a Masters in Public Health degree in epidemiology at the University of Washington in 1994, where she also completed a fellowship in infectious diseases. She completed a STD/HIV Prevention Epidemiology and Public Health Fellowship at the Centers for Disease Control and Prevention in 1994, and joined the faculty at the University of Washington in 1996.
Paul Martin, MD
Dr. Martin, a board certified internist and gastroenterologist with additional certification in transplant hepatology, is the Chief of the Division of Hepatology at the University of Miami Miller School of Medicine.
Dr. Martin has a major interest in viral hepatitis, advanced liver disease and organ transplantation and has published widely on these topics. He is an associate editor for Alimentary Pharmacology and Therapeutics and is a member of several editorial boards for a number of journals including Liver Transplantation. He currently serves on the Board of the American Society of Transplant and as Chair of ABIM's Subspecialty Board on Gastroenterology Test Writing Committee. He is a fellow of the Royal Colleges of Physicians of Ireland and of London.
Dr. Martin earned his medical degree at University College, Dublin. He trained in Internal Medicine at the University of Alberta in Edmonton and gastroenterology at Queen’s University, Ontario Canada. He trained as a Medical Staff Fellow in the Liver Unit at the National Institutes of Health, Bethesda, Maryland.
Lesley A. Meng, MD
Dr. Meng is a native New Orleanian who was displaced by Hurricane Katrina and though she was successfully practicing medicine in Scottsdale, Arizona, she desperately wanted to return and rebuild her practice in Louisiana. Her commitment to her patients is remarkable. She is a medical oncologist who takes pride in seeing patients often within 24 hours of their initial phone call. She has done a great deal of cancer research and believes strongly in preventive and screening programs.
In May 2005, a year after finishing her Fellowship in Hematology/Oncology, Dr. Meng opened a two-location solo practice in New Orleans. In 2005, Hurricane Katrina washed it all away. She relocated to Scottsdale, Arizona and started over. There, she founded Desert Springs Cancer Care and designed and built a comprehensive care center. She had a successful practice and enjoyed Scottsdale, but, in 2012, decided to return to New Orleans.
She is now a hospital-employed physician and member of the East Jefferson General Hospital (EJGH) Physician Group. EJGH is a 420-bed not-for-profit community hospital. Extremely active in the community, Dr. Meng is committed to EJGH and providing the most innovative, effective and highest levels of cancer care possible.
Dr. Meng is a member of the Pharmacy and Therapeutics Committee at EJGH and is involved with the design and development of a new cancer suite at EJGH. She has served on the Utilization Review Committee, participated in the Oncology Survivorship Program, and is the Clinical Trial Coordinator for the Physician Network at EJGH. In Arizona, she was on the Board of the Arizona Foundation for Medical Care, the Board of the Arizona State Physicians Association, the Arizona Regulatory Board of Physician Assistants, and the Physician Advisory Board for Paradise Valley Hospital.
She earned a bachelor’s degree in biochemistry from Louisiana State University, and her medical degree from Louisiana State University Medical Center, where she completed an internal medicine internship, residency and fellowship training in hematology oncology.
Michael R. Nelson, MD
Dr. Nelson, board certified in Allergy and Immunology by the American Board of Allergy and Immunology, is Deputy Commander for Education, Training & Research at the Walter Reed National Military Medical Center. In addition, he serves as the Allergy-Immunology Consultant to the U.S. Army Office of the Surgeon General and is also the Program Director for the National Capital Consortium Allergy-Immunology Fellowship.
Dr. Nelson's other roles include Treasurer of the American Board of Allergy and Immunology, Vice-Chair of the ACGME Allergy-Immunology Residency Review Committee and Associate Professor of Medicine and Pediatrics for the Uniformed Services University of the Health Sciences. He has authored multiple papers, is an editor for the Joint Council of Allergy & Immunology Allergen Extract Preparation Written Examination and serves as a reviewer for the Project Immune Readiness, Allergy-Immunology Web-based continuing education modules.
Dr. Nelson received his medical degree and PhD in Pharmacology from the University of Virginia, where he also completed his internship in Internal Medicine. He went on to serve his residency at the Eisenhower Army Medical Center and later completed Allergy/Immunology and Clinical Laboratory Fellowships at the Walter Reed National Military Medical Center.
Naomi P. O'Grady, MD
Dr. O’Grady, who is board certified in Infectious Disease and Critical Care Medicine, is a senior staff physician in the National Institutes of Health (NIH) Clinical Center’s Critical Care Medicine Department and the Medical Director of the Clinical Center’s Vascular Access and Conscious Sedation Services. She also is an Attending Physician with the Pediatric Critical Care Medicine Department of the Children’s National Medical Center and an Assistant Professor in the Department of Internal Medicine’s Division of Infectious Diseases at Johns Hopkins University School of Medicine.
Dr. O’Grady’s research interests include strategies to reduce the incidence of antimicrobial resistant pathogens in the ICU and catheter-related blood stream infections. She is also actively involved in guideline development and implementation, having chaired the Infectious Diseases Society’s Guidelines Committee for three years. In addition, she has authored several guidelines related to fever in the ICU and catheter-related bloodstream infections.
Dr. O’Grady serves on the ABIM Council as Chair of the ABIM Subspecialty Board on Critical Care Medicine. She is a Fellow of the American College of Critical Care Medicine and of the Infectious Diseases Society of America.
A graduate of the University of Michigan, Dr. O’Grady earned her medical degree at Ohio State University and completed fellowships with NIH and Johns Hopkins University.
Dr. O'Grady serves in a personal capacity and does not represent the National Institutes of Health or the Department of Health and Human Services.
Dana Safran, ScD
Dana Gelb Safran is Senior Vice President for Performance Measurement and Improvement at Blue Cross Blue Shield of Massachusetts (BCBSMA). In this role, she leads the company’s initiatives to measure and improve healthcare quality, safety and outcomes. Dr. Safran was among the lead developers of the BCBSMA Alternative Quality Contract (AQC), a provider contract model launched in 2009 with the twin goals of improving quality and outcomes while significantly slowing spending growth. Dr. Safran also retains an active academic practice, as a faculty member in the Department of Medicine at Tufts University School of Medicine, and has authored more than 75 peer-reviewed articles.
She is widely recognized as having contributed to the empirical basis for our nation’s push toward a more patient-centered health care system – and for developing measures of patient care experiences that are now used nationwide, accepted as a national standard for this area of measurement, and used by the Medical Boards as part of their recertification process for physicians.
Dr. Safran’s advisory roles on national and local quality measurement include work with the Office of the National Coordinator, the Centers for Medicare and Medicaid Services, the American Board of Internal Medicine, the National Quality Forum, the National Committee for Quality Assurance, the Editorial Board of Healthcare: The Journal of Delivery Science and Innovation, and the Patient Centered Primary Care Collaborative. At the state level, Dr. Safran serves on the Board of Directors for the Blue Cross Blue Shield Foundation, Associated Early Care and Education, and Massachusetts Health Quality Partners, and is a member of the Massachusetts Statewide Quality Advisory Council.
Dr. Safran earned her master’s and Doctor of Science degrees in Health Policy from the Harvard School of Public Health.Top
Richard M. Stone, MD
Dr. Stone, who is board certified in Internal Medicine, Medical Oncology and Hematology, is the Director of the Adult Acute Leukemia Program at Dana-Farber, and Professor of Medicine at Harvard Medical School.
He is nationally recognized for his translational and clinical research concerning blood and bone marrow malignancies including acute leukemia, myeloproliferative disorders and myelodysplastic syndrome [MDS] (a bone marrow failure state that may convert to leukemia).
In addition to his work at Dana-Farber, Dr. Stone serves as Chair of the Subspecialty Board on Medical Oncology Board of the American Board of Internal Medicine and is a member of the ABIM Council, Chair of the Medical Advisory Board of the Aplastic Anemia & MDS International Foundation and Chairman of the Leukemia Core Committee for the national cooperative trials group the Alliance.
Dr. Stone earned his medical degree from Harvard Medical School in 1981. He completed his internal medicine residency training at Brigham and Women’s Hospital, and his Hematology-Oncology fellowship at Dana-Farber.
Henry H. Ting, MD
Dr. Ting, a board certified cardiologist and interventional cardiologist, is assuming a new role in July 2014 as Senior Vice President and Chief Quality Officer of NewYork-Presbyterian Hospital and Healthcare System, the University Hospital of Columbia and Cornell. Formerly, Dr. Ting was a Professor of Medicine at Mayo Clinic College of Medicine and his clinical practice included interventional and clinical cardiology. At Mayo Clinic, Dr. Ting has served as the Associate Dean for Mayo Clinic College of Medicine; as the Director for Mayo Clinic Quality Academy that oversees quality improvement education, training, and coaching for all 60,000 Mayo Clinic staff; on the Mayo Clinic Quality Committee that oversees organizational quality, safety, and patient experience; as Clinical Practice Chair of the Mayo Clinic Division of Cardiovascular Diseases; and as Chair of Regional Cardiology of the Mayo Clinic Health System.
Dr. Ting serves on multiple national committees including: the National Quality Forum Cardiovascular Steering Committee that endorses performance measures for public reporting and accountability; the American Board of Internal Medicine Product Oversight Committee for Maintenance of Certification across all subspecialties of internal medicine; the American College of Cardiology and American Heart Association Task Force on Performance Measures; the American College of Cardiology Clinical Quality Committee; Editorial Board for Circulation: Cardiovascular Quality and Outcomes; the American College of Cardiology and American Heart Association Guidelines Writing Committees for Percutaneous Coronary Interventions and Perioperative Cardiovascular Evaluation and Care for Non-cardiac Surgery; and the American Heart Association Mission Lifeline Advisory Working Group.
Dr. Ting’s scholarly activities focus on health services research and shared decision making to improve practice performance and population health. He is the principal investigator of: (1) a national quality initiative funded by AHRQ to disseminate and implement strategies to improve organizational culture, leadership, and teamwork associated with lower 30-day mortality rates for patients with acute myocardial infarction; and (2) a randomized controlled trial to evaluate the efficacy of shared decision making tools for patients with stable angina choosing between percutaneous coronary intervention versus medical therapy. Dr. Ting has successfully led quality improvement initiatives at the local, regional, and national levels including the Door-to-Balloon Alliance to reduce time to reperfusion therapy for patients with ST-elevation myocardial infarction at over 1000 hospitals and the Hospital-to-Home: Excellence in Transitions of Care to reduce 30-day readmission rates for patients hospitalized with congestive heart failure at over 1000 hospitals. Dr. Ting has over 120 publications in peer-reviewed journals including the New England Journal of Medicine and Journal of the American Medical Association. He has been a keynote and plenary speaker at national and international conferences.
Dr. Ting earned a bachelor’s degree in Chemistry from Cornell University, a medical degree from Harvard Medical School, a master’s in business administration from University of St. Thomas in Minneapolis, Minnesota, and received training in Biostatistics and Epidemiology from the Harvard School of Public Health Clinical Effectiveness Program. He completed residency in internal medicine and fellowships in cardiovascular diseases and interventional cardiology at Brigham and Women’s Hospital. He has also received training in quality improvement methodologies including Lean, Six-Sigma, Change Management, Value Network Analysis, and Baldrige Model for performance excellence.
Jeffrey Wiese, MD
Dr. Wiese, who is board certified in internal and hospital medicine, is currently a Professor of Medicine and Associate Dean of Graduate Medical Education at Tulane University.
Dr. Wiese has written more than 60 articles, books or book chapters, and is a reviewer or editorial board member for a number of medical journals. An award-winning instructor at Tulane University, Dr. Wiese has received more than 30 awards for teaching, including the prestigious All-Tulane Faculty of the Year Award and the Virginia Furrow Award for Innovation in Medical Education. In 2005, he was awarded the SHM National Award for Excellence in Teaching.
The main areas of professional interest for Dr. Wiese include healthcare reform, medical education and hospital finance/management. Additionally, Dr. Wiese was President of the Society of Hospital Medicine in 2010 and currently serves as Chair of ABIM's Hospital Medicine Exam Writing Committee.
Dr. Wiese earned his bachelor's degree from Drake University in Des Moines, Iowa, and his medical degree from The Johns Hopkins School of Medicine. He went on to complete an internal medicine residency at the University of California at San Francisco, where he later completed a medical education fellowship.
Michael E. Williams, MD
Dr. Williams, board certified in internal medicine, medical oncology and hematology, is the Byrd S. Leavell Professor of Medicine, Professor of Pathology, Chief, Hematology/Oncology Division and Director, Hematologic Malignancies Section, University of Virginia School of Medicine, Charlottesville.
His research interests are in the pathogenesis and therapy of non-Hodgkin lymphoma and chronic lymphocytic leukemia, and in targeted therapeutic approaches for hematologic malignancies.
Dr. Williams serves on the Scientific Advisory Board of the Lymphoma Research Foundation, and is a member of the Scientific Advisory Board of the European Mantle Cell Lymphoma Network. He serves as Vice-Chair of the Eastern Cooperative Oncology Group/ACRIN Lymphoma Core Committee. He is Chair of the Hematology Subspecialty Board of the American Board of Internal Medicine and participates regularly in national and international programs devoted to education and research in lymphoma and hematologic malignancies.
Dr. Williams received his medical degree from the University of Cincinnati College of Medicine and a Master of Science from the Harvard School of Public Health. He completed his medicine residency, chief residency, and fellowship in hematology/oncology at the University of Virginia Health System in Charlottesville, where he joined the faculty in 1986.
William F. Young Jr., MD
Dr. Young, a board certified internist and endocrinologist, is the Tyson Family Endocrinology Clinical Professor, and Chair of the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at the Mayo Clinic in Rochester, MN. He is a practicing endocrinologist with an active clinical practice and a dedicated teacher and mentor to residents and endocrinology fellows.
Currently, Dr. Young serves as a member of the ABIM Endocrinology Exam Writing Committee and member of the ABIM Board of Endocrinology, Diabetes, and Metabolism. Dr. Young is an internationally recognized endocrinologist who has served as past President of the Endocrine Society, past Chair of the Endocrine Society Self Assessment Committee, an Associate Editor for the Journal of Clinical Endocrinology and Metabolism, and as a Senior Editor for Clinical Endocrinology. He is past Chair of the Endocrine Society’s Annual Meeting Steering Committee and Nominating Committee. Dr. Young has published over 240 articles on endocrine hypertension and adrenal and pituitary disorders. He has been the recipient of multiple education awards and has presented at over 300 national and international meetings and he has been an invited visiting professor for more than 100 medical institutions.
Dr. Young earned his medical degree at the Michigan State University. He completed his internal medicine residency at William Beaumont Hospital and later completed fellowship training in endocrinology at Mayo Clinic.